SUVENPHAR.BOSUVENPHAR.BOBSE
Loading
Operating Income PerformanceStable
Percentile Rank67
3Y CAGR-3.7%
5Y CAGR+6.3%
Year-over-Year Change
Profit from core business operations before interest and taxes
3Y CAGR
-3.7%/yr
Annual compound
5Y CAGR
+6.3%/yr
Recent deceleration
Percentile
P67
Within normal range
vs 5Y Ago
1.4x
Solid growth
Streak
1 yr
Consecutive growthStable
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $5.66B | +4.7% |
| 2024 | $5.40B | -14.3% |
| 2023 | $6.30B | -0.5% |
| 2022 | $6.33B | +31.1% |
| 2021 | $4.83B | +16.1% |
| 2020 | $4.16B | -8.2% |
| 2019 | $4.53B | - |